4/1
07:22 am
tech
Data Showcasing ALZpath's Proprietary pTau217 Antibody at AD/PD™ 2025 Demonstrates High Rate of Reliability and Scalability for Alzheimer's Disease Research and Diagnosis [Yahoo! Finance]
Low
Report
Data Showcasing ALZpath's Proprietary pTau217 Antibody at AD/PD™ 2025 Demonstrates High Rate of Reliability and Scalability for Alzheimer's Disease Research and Diagnosis [Yahoo! Finance]
3/31
08:39 am
tech
3 Reasons to Avoid TECH and 1 Stock to Buy Instead [Yahoo! Finance]
Low
Report
3 Reasons to Avoid TECH and 1 Stock to Buy Instead [Yahoo! Finance]
3/26
11:04 pm
tech
Bio-Techne Co. (NASDAQ: TECH) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.
Low
Report
Bio-Techne Co. (NASDAQ: TECH) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.
3/26
08:00 am
tech
Bio-Techne Announces New Customer Experience Centre in Düsseldorf, Germany [Yahoo! Finance]
Low
Report
Bio-Techne Announces New Customer Experience Centre in Düsseldorf, Germany [Yahoo! Finance]
3/26
07:00 am
tech
Bio-Techne Announces New Customer Experience Centre in Düsseldorf, Germany
Low
Report
Bio-Techne Announces New Customer Experience Centre in Düsseldorf, Germany
3/24
09:38 am
tech
2 High-Flying Stocks to Target This Week and 1 to Brush Off [Yahoo! Finance]
Low
Report
2 High-Flying Stocks to Target This Week and 1 to Brush Off [Yahoo! Finance]
3/24
07:11 am
tech
Bio-Techne to Highlight Advances in the Detection of Clinically Relevant Biomarkers using RNAscope Technologies at the 2025 USCAP Annual Meeting [Yahoo! Finance]
Low
Report
Bio-Techne to Highlight Advances in the Detection of Clinically Relevant Biomarkers using RNAscope Technologies at the 2025 USCAP Annual Meeting [Yahoo! Finance]
3/24
07:00 am
tech
Bio-Techne to Highlight Advances in the Detection of Clinically Relevant Biomarkers using RNAscope Technologies at the 2025 USCAP Annual Meeting
Low
Report
Bio-Techne to Highlight Advances in the Detection of Clinically Relevant Biomarkers using RNAscope Technologies at the 2025 USCAP Annual Meeting
3/18
08:06 am
tech
Bio-Techne Co. (NASDAQ: TECH) is now covered by analysts at Evercore ISI. They set an "outperform" rating and a $75.00 price target on the stock.
Low
Report
Bio-Techne Co. (NASDAQ: TECH) is now covered by analysts at Evercore ISI. They set an "outperform" rating and a $75.00 price target on the stock.
3/18
02:07 am
tech
Bio-Techne Co. (NASDAQ: TECH) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Low
Report
Bio-Techne Co. (NASDAQ: TECH) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
3/12
09:42 am
tech
Research Tools & Consumables Stocks Q4 Recap: Benchmarking Bruker (NASDAQ:BRKR) [Yahoo! Finance]
Medium
Report
Research Tools & Consumables Stocks Q4 Recap: Benchmarking Bruker (NASDAQ:BRKR) [Yahoo! Finance]
3/12
08:17 am
tech
TECH Stock Might Rise Following the Leo Shipping Announcement [Yahoo! Finance]
Low
Report
TECH Stock Might Rise Following the Leo Shipping Announcement [Yahoo! Finance]
3/10
11:02 pm
tech
Bio-Techne Co. (NASDAQ: TECH) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.
Medium
Report
Bio-Techne Co. (NASDAQ: TECH) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.
3/10
07:00 am
tech
Bio-Techne Begins Shipping Leo - A Next Generation High-Throughput Simple Western System
Low
Report
Bio-Techne Begins Shipping Leo - A Next Generation High-Throughput Simple Western System
3/7
07:07 pm
tech
Techne (TECH) Down 15.5% Since Last Earnings Report: Can It Rebound? [Yahoo! Finance]
Low
Report
Techne (TECH) Down 15.5% Since Last Earnings Report: Can It Rebound? [Yahoo! Finance]
3/4
12:48 pm
tech
Bio-Techne Co. (NASDAQ: TECH) had its price target lowered by analysts at Citigroup Inc. from $80.00 to $70.00. They now have a "neutral" rating on the stock.
Low
Report
Bio-Techne Co. (NASDAQ: TECH) had its price target lowered by analysts at Citigroup Inc. from $80.00 to $70.00. They now have a "neutral" rating on the stock.
3/4
05:59 am
tech
Unpacking Q4 Earnings: Danaher (NYSE:DHR) In The Context Of Other Research Tools & Consumables Stocks [Yahoo! Finance]
Medium
Report
Unpacking Q4 Earnings: Danaher (NYSE:DHR) In The Context Of Other Research Tools & Consumables Stocks [Yahoo! Finance]
3/3
07:17 am
tech
Bio-Techne Launches New Panel Resolving Hard-to-Decipher Carrier Screening Genes [Yahoo! Finance]
Low
Report
Bio-Techne Launches New Panel Resolving Hard-to-Decipher Carrier Screening Genes [Yahoo! Finance]
3/3
07:11 am
tech
Winners And Losers Of Q4: Revvity (NYSE:RVTY) Vs The Rest Of The Research Tools & Consumables Stocks [Yahoo! Finance]
Low
Report
Winners And Losers Of Q4: Revvity (NYSE:RVTY) Vs The Rest Of The Research Tools & Consumables Stocks [Yahoo! Finance]
3/3
07:00 am
tech
Bio-Techne Launches New Panel Resolving Hard-to-Decipher Carrier Screening Genes
Low
Report
Bio-Techne Launches New Panel Resolving Hard-to-Decipher Carrier Screening Genes
2/27
07:27 am
tech
Bio-Techne to Present at Investor Conferences [Yahoo! Finance]
Medium
Report
Bio-Techne to Present at Investor Conferences [Yahoo! Finance]
2/27
07:00 am
tech
Bio-Techne to Present at Investor Conferences
Medium
Report
Bio-Techne to Present at Investor Conferences
2/25
08:35 am
tech
What To Expect From Agilent's (A) Q4 Earnings [Yahoo! Finance]
Low
Report
What To Expect From Agilent's (A) Q4 Earnings [Yahoo! Finance]
2/20
08:17 am
tech
Bio-Techne Co. (NASDAQ: TECH) was downgraded by analysts at Baird R W from a "strong-buy" rating to a "hold" rating.
Low
Report
Bio-Techne Co. (NASDAQ: TECH) was downgraded by analysts at Baird R W from a "strong-buy" rating to a "hold" rating.
2/20
07:34 am
tech
Bio-Techne Launches Expanded Menu of RNAscope Probes for Human and Mouse Transcriptome to Advance Spatial Biology [Yahoo! Finance]
Low
Report
Bio-Techne Launches Expanded Menu of RNAscope Probes for Human and Mouse Transcriptome to Advance Spatial Biology [Yahoo! Finance]